M M Walle-Hansen1, A H Ranhoff2,3, M Mellingsæter4, M S Wang-Hansen5, M Myrstad6,7. 1. Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, N-1346, Gjettum, Norway. marte@hansencorp.eu. 2. Department of Medicine, Diakonhjemmet Hospital, Oslo, Norway. 3. Department of Clinical Science, University of Bergen, Bergen, Norway. 4. Department of Geriatric Medicine, Akershus University Hospital, Lørenskog, Norway. 5. Department of Geriatric Medicine, Vestfold Hospital Trust, Tønsberg, Norway. 6. Department of Medical Research, Bærum Hospital, Vestre Viken Hospital Trust, N-1346, Gjettum, Norway. 7. Department of Internal Medicine, Bærum Hospital, Vestre Viken Hospital Trust, N-1346, Gjettum, Norway.
Abstract
BACKGROUND: Older people are particularly vulnerable to severe COVID-19. Little is known about long-term consequences of COVID-19 on health-related quality of life (HR-QoL) and functional status in older people, and the impact of age in this context. We aimed to study age-related change in health-related quality of life, functional decline and mortality among older patients 6 months following hospitalisation due to COVID-19. METHODS: This was a cohort study including patients aged 60 years and older admitted to four general hospitals in South-Eastern Norway due to COVID-19, from March 1 up until July 1, 2020. Patients who were still alive were invited to attend a six-month follow-up. Change in HR-QoL and functional status compared to before the COVID-19 hospitalisation were assessed using the EuroQol 5-dimensional-5 levels questionnaire (EQ. 5D-5L). A change in visual analogue scale (VAS) score of 7 or more was considered clinically relevant. RESULTS: Out of 216 patients aged 60 years and older that were admitted to hospital due to COVID-19 during the study period, 171 were still alive 180 days after hospital admission, and 106 patients (62%) attended the six-month follow-up. Mean age was 74.3 years, 27 patients (26%) had experienced severe COVID-19. Fifty-seven participants (54%) reported a decrease in the EQ. 5D-5L VAS score after 6 months, with no significant difference between persons aged 75 years and older compared to younger. Seventy participants (66%) reported a negative change in any of the dimensions of the EQ. 5D-5L, with impaired ability to perform activities of daily life (35%), reduced mobility (33%) and having more pain or discomfort (33%) being the most commonly reported changes. Forty-six participants (43%) reported a negative change in cognitive function compared to before the COVID-19 hospitalisation. Six-month mortality was 21%, and increased with increasing age. CONCLUSIONS: More than half of the patients reported a negative change in HR-QoL 6 months following hospitalisation due to COVID-19, and one out of three experienced a persistently impaired mobility and ability to carry out activities of daily living. The results suggest awareness of long-term functional decline in older COVID-19 patients.
BACKGROUND: Older people are particularly vulnerable to severe COVID-19. Little is known about long-term consequences of COVID-19 on health-related quality of life (HR-QoL) and functional status in older people, and the impact of age in this context. We aimed to study age-related change in health-related quality of life, functional decline and mortality among older patients 6 months following hospitalisation due to COVID-19. METHODS: This was a cohort study including patients aged 60 years and older admitted to four general hospitals in South-Eastern Norway due to COVID-19, from March 1 up until July 1, 2020. Patients who were still alive were invited to attend a six-month follow-up. Change in HR-QoL and functional status compared to before the COVID-19 hospitalisation were assessed using the EuroQol 5-dimensional-5 levels questionnaire (EQ. 5D-5L). A change in visual analogue scale (VAS) score of 7 or more was considered clinically relevant. RESULTS: Out of 216 patients aged 60 years and older that were admitted to hospital due to COVID-19 during the study period, 171 were still alive 180 days after hospital admission, and 106 patients (62%) attended the six-month follow-up. Mean age was 74.3 years, 27 patients (26%) had experienced severe COVID-19. Fifty-seven participants (54%) reported a decrease in the EQ. 5D-5L VAS score after 6 months, with no significant difference between persons aged 75 years and older compared to younger. Seventy participants (66%) reported a negative change in any of the dimensions of the EQ. 5D-5L, with impaired ability to perform activities of daily life (35%), reduced mobility (33%) and having more pain or discomfort (33%) being the most commonly reported changes. Forty-six participants (43%) reported a negative change in cognitive function compared to before the COVID-19 hospitalisation. Six-month mortality was 21%, and increased with increasing age. CONCLUSIONS: More than half of the patients reported a negative change in HR-QoL 6 months following hospitalisation due to COVID-19, and one out of three experienced a persistently impaired mobility and ability to carry out activities of daily living. The results suggest awareness of long-term functional decline in older COVID-19patients.
Entities:
Keywords:
COVID-19; Geriatric medicine; Health-related quality of life; Pandemic
Authors: Safiya Richardson; Jamie S Hirsch; Mangala Narasimhan; James M Crawford; Thomas McGinn; Karina W Davidson; Douglas P Barnaby; Lance B Becker; John D Chelico; Stuart L Cohen; Jennifer Cookingham; Kevin Coppa; Michael A Diefenbach; Andrew J Dominello; Joan Duer-Hefele; Louise Falzon; Jordan Gitlin; Negin Hajizadeh; Tiffany G Harvin; David A Hirschwerk; Eun Ji Kim; Zachary M Kozel; Lyndonna M Marrast; Jazmin N Mogavero; Gabrielle A Osorio; Michael Qiu; Theodoros P Zanos Journal: JAMA Date: 2020-05-26 Impact factor: 56.272
Authors: Fanni Rencz; Peter L Lakatos; László Gulácsi; Valentin Brodszky; Zsuzsanna Kürti; Szilvia Lovas; János Banai; László Herszényi; Tamás Cserni; Tamás Molnár; Márta Péntek; Károly Palatka Journal: Qual Life Res Date: 2018-09-17 Impact factor: 4.147
Authors: Jessamine Y J Liu; Esmee M Reijnierse; Jeanine M van Ancum; Sjors Verlaan; Carel G M Meskers; Andrea B Maier Journal: PLoS One Date: 2019-04-15 Impact factor: 3.240
Authors: Jesse J Aarden; Marike van der Schaaf; Martin van der Esch; Lucienne A Reichardt; Rosanne van Seben; Jos A Bosch; Jos W R Twisk; Bianca M Buurman; Raoul H H Engelbert Journal: PLoS One Date: 2019-07-05 Impact factor: 3.240
Authors: Verena Rass; Bogdan-Andrei Ianosi; Laura Zamarian; Ronny Beer; Sabina Sahanic; Anna Lindner; Mario Kofler; Alois Josef Schiefecker; Philipp Mahlknecht; Beatrice Heim; Victoria Limmert; Thomas Sonnweber; Alex Pizzini; Piotr Tymoszuk; Christoph Scherfler; Atbin Djamshidian; Stefan Kiechl; Ivan Tancevski; Klaus Seppi; Bettina Pfausler; Judith Loeffler-Ragg; Raimund Helbok Journal: Qual Life Res Date: 2021-09-28 Impact factor: 3.440
Authors: Sari Harenwall; Suzanne Heywood-Everett; Rebecca Henderson; Sherri Godsell; Sarah Jordan; Angela Moore; Ursula Philpot; Kirsty Shepherd; Joanne Smith; Amy Rachel Bland Journal: J Prim Care Community Health Date: 2021 Jan-Dec
Authors: Destin Groff; Ashley Sun; Anna E Ssentongo; Djibril M Ba; Nicholas Parsons; Govinda R Poudel; Alain Lekoubou; John S Oh; Jessica E Ericson; Paddy Ssentongo; Vernon M Chinchilli Journal: JAMA Netw Open Date: 2021-10-01
Authors: Carl Wahlgren; Anestis Divanoglou; Melanie Larsson; Emma Nilsson; Åse Östholm Balkhed; Katarina Niward; Ulrika Birberg Thornberg; Eva Lilliecreutz Gudmundsson; Richard Levi Journal: EClinicalMedicine Date: 2021-12-05